Wearable ECG biosensor
A lightweight, single-use chest patch continuously records two-channel ECG and patient-marked events for an extended monitoring period.
An all-inclusive Holter pathway combining a lightweight ECG patch, secure cloud reporting and technician-reviewed preliminary reports ready for clinical interpretation.
Holter reporting workspace
Illustrative clinical workflow
De-identified study
Extended ECG recording
Data
Recovered
Analysis
Reviewed
Report
Awaiting sign-off
Wearable biosensor
Continuous ECG recording
Jace connects the patient-wear experience with the operational support needed to return a usable preliminary report to the clinical team.
A lightweight, single-use chest patch continuously records two-channel ECG and patient-marked events for an extended monitoring period.
Recorded data is uploaded into a controlled online environment for review, reporting and authorised access.
A cardiac technician reviews the recording and prepares a preliminary report ready for the responsible clinician’s interpretation.
The LifeSignals 1AXe is a single-use, chest-worn Holter biosensor. Its wire-free design records ECG during daily life without a separate recorder box or loose leads.
Patients still need clear fitting, event-recording, water-exposure and return instructions. The technology simplifies the experience; it does not remove the need for a well-managed clinical pathway.
View the 1AXe biosensorContinuous ECG recording with heart-rate and patient-activated event information.
Extended wear can increase the opportunity to capture intermittent symptoms and rhythm events.
The 28g chest-worn patch avoids a separate recorder box and trailing lead wires.
Patients can sleep, move and follow the supplied water-resistance guidance while recording continues.
Wear duration, specifications and available workflow options can vary by market, regulatory clearance and service configuration.
A defined handoff at every stage helps keep the service safe, traceable and easier to scale.
The patient is enrolled in the agreed workflow and the single-use biosensor is applied to the upper chest.
ECG and event data are collected continuously while the patient follows the wear and symptom-diary instructions.
After monitoring, the biosensor data is securely transferred through the configured clinic or patient workflow.
A technician-reviewed preliminary report is made available for clinician review, interpretation and sign-off.
Technician review and ECG analysis can reduce the manual burden of preparing a Holter study, but the report remains preliminary until an appropriately qualified clinician interprets and signs it in context.
Clinical reporting workflow
Controlled access and clear responsibility
Technician review
Preliminary findings and quality checks
Waveform access
Review the underlying ECG recording
Clinical comment
Add interpretation and follow-up
Authorisation
Sign-off with a traceable audit trail
Exact conventional Holter arrangements vary. This comparison focuses on the practical differences created by a single-use wireless patch and cloud reporting pathway.
The workflow can be shaped around different enrolment volumes, reporting responsibilities and access requirements.
Add extended Holter capability without building an entire analysis and reporting operation internally.
Offer a consistent monitoring pathway with cloud access and an operational workflow that can grow with demand.
Support higher-volume ambulatory ECG pathways with structured reporting and authorised team access.
Build an enrolment model around patients who need monitoring beyond a conventional hospital department.
Practical questions about device wear, clinical responsibility, data access and provider scale.
Onboarding defines the service
Volumes, turnaround, governance and clinical ownership should be agreed before launch.
The service is designed to combine a single-use wearable ECG biosensor, the configured data-upload and cloud workflow, and a technician-reviewed preliminary Holter report. Exact onboarding, device supply, turnaround and clinical responsibilities should be agreed with Jace for your organisation.
Provider enquiries
Tell Jace about your current pathway, expected volume and reporting requirements. The team can explain the available configuration and next steps.
UltraLinQ supports planned ambulatory cardiac investigation and reporting. It is not an emergency monitoring service. Patients with severe or rapidly worsening symptoms should follow urgent or emergency-care guidance.